Cancer surveillance in non-alcoholic fatty liver disease: A potential role for lipidomics

Within the past two decades, non-alcoholic fatty liver disease (NAFLD) emerged as the most prevalent chronic liver disease in western civilizations. Concerningly, this trend could recently be observed globally, especially in high-income Asia Pacific, East Asia, Latin, and Central America. Accordingly, the incidence of NAFLD-associated hepatocellular cancer (HCC) is increasing dramatically, progressively replacing other etiologies (i.e. viral...